The reasons for this are unclear
If clinically appropriate, the prescription is written
Comparison with Topiramate: The study matched 11,000 GLP-1 users against 11,000 topiramate users, adjusting for age, BMI, and prior health conditions
Full results from IV drip skin treatment depend on consistency and lifestyle
Semaglutide: Single-Receptor Approach Semaglutide activates the GLP-1 receptor, producing the following effects: Appetite suppression through direct action on hypothalamic neurons that control hunger signaling Delayed gastric emptying that promotes prolonged feelings of fullness after meals Enhanced glucose-dependent insulin secretion from pancreatic beta cells Reduced glucagon secretion (different from glucagon receptor activation) that lowers hepatic glucose output Potential neuroprotective effects currently being studied in Alzheimers disease trials Research by Blundell et al
Anticonvulsant hypersensitivity syndrome: incidence, prevention and management